Escherichia coli (n ‫؍‬ 1439), isolated from the feces of apparently healthy grow-finish pigs in 20 herds, were tested for susceptibility to 16 antimicrobials. Logistic regression models were developed for each resistance that was observed in more than 5% of the isolates. Each production phase's (suckling, nursery, grow-finish pigs or sows) antimicrobial exposure rate, through feed or water, was considered as a risk factor. Management variables were evaluated as potential confounders. Six resistance outcomes were associated with an antimicrobial use risk factor and four included exposures of pigs outside the grow-finish phase. In the case of sulfamethoxazole, the odds of resistance increased 2.3 times for every 100,000 pig-days of nursery pig exposure to sulfonamides. Thus, swine producers and veterinarians must be aware that antimicrobial use in pigs distant from market could have food safety repercussions. Five resistance outcomes were associated with exposure to an unrelated antimicrobial class. Most notably, the odds of sulfamethoxazole and chloramphenicol resistance were each six times higher in herds reporting high (more than 500/1,000 pig-days) grow-finish pig, macrolide exposure compared to herds with no macrolide use in grow-finish pigs. Therefore, the potential for co-selection should be considered in antimicrobial use decisions. This study emphasizes the importance of judicious antimicrobial use in pork production. 261 
INTRODUCTION S
WINE VETERINARIANS AND PRODUCERS use antimicrobials to treat and prevent bacterial infections, improving pig health and welfare. Antimicrobials are also used as feed additives to increase daily gain and improve feed efficiency. 15, 32, 33 Although antimicrobials are indispensable tools for managing bacterial disease, their use also contributes to acquired antimicrobial resistance (AMR) in commensal and pathogenic bacteria. 1, 5, 16, 19, 30, 32, 42, 51 Resistant bacteria can survive and propagate in the presence of antimicrobials. Some bacteria are intrinsically resistant, whereas others develop resistance through chromosomal mutations or by acquiring resistance genes. 36, 42 Horizontal transmission of resistance genes occurs through plasmids, transposons, and integrons. These elements can carry multiple resistance genes and transmit them as a unit. 6, 42, 44, 46 Therefore, bacteria with acquired AMR are frequently resistant to unrelated drugs.
Resistant zoonotic pathogens, such as Salmonella spp., pose a direct risk to consumers eating contaminated pork. 28, 34 Resistant pathogens have an higher infection rate, limited treatment options, and increased virulence. 5, 47, 52 Resistant commensal organisms are also a food safety hazard. Although the magnitude of this risk is undefined, resistance genes may spread to other bacteria in the human gastrointestinal tract. 1, 27, 41, 43, 51 Furthermore, commensal bacteria reflect the selective pressures for resistance to develop in the normal intestinal flora. 22, 51 Research and surveillance projects often use Escherichia coli as a model for AMR in Gram-negative commensals. 19, 22, 25, 30, 45, 50 The ubiquity of E. coli allows AMR to be compared between populations of healthy animals. 22, 51 Experimentally, antimicrobial exposure increases the prevalence of resistant E. coli in healthy pigs. 7, 16, 30 On-farm studies have also shown antimicrobial use is associated with E. coli AMR. 2, 19, 21 Observational studies are ideal for investigating complex problems with many causes or hypotheses. 17 These studies can consider numerous drug exposures and various resistances simultaneously. To date, observational investigations have not considered the extent of antimicrobial exposure within herds. 2, 19 Therefore, the objective of this project was to investigate the dose-response relationships between on-farm antimicrobial use and AMR in E. coli from grow-finish pigs.
MATERIALS AND METHODS

Herd enrollment
A convenience sample of 20 herds was enrolled with the assistance of eight swine veterinarians in Saskatchewan (13 herds) and Alberta (7 herds). Herds were selected by the veterinarians and met the inclusion criteria of having more than 100 sows and participation in the Canadian Quality Assurance ® (CQA ® ) Program. 12 Each veterinarian enrolled two to four herds. Study herds were visited once between May and September of 2004 to collect fecal samples, antimicrobial use data, and information on animal inventory and production practices (Table 1) . 
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Sample collection, E. coli isolation, and antimicrobial susceptibility analysis
A random numbers table was used to identify 20 pens of clinically healthy grow-finish pigs in each herd. Freshly voided feces were collected from 5 pigs in each of these pens, and pooled to create a pen sample. Samples were cultured for E. coli within 24 hr of collection by a commercial veterinary laboratory (Prairie Diagnostic Services (PDS), University of Saskatchewan, Saskatoon, SK). Samples were streaked onto whole blood agar and MacConkey plates, and incubated at 37°C for 18 hr. Each sample had three lactose-positive colonies harvested, unless distinct colony types, such as hemolytic and nonhemolytic, or mucoid and dry, were identified; up to six isolates were harvested from these samples. Triple Sugar Iron/Indole testing confirmed isolates were E. coli. Pure, confirmed E. coli cultures were kept frozen in 25% glycerol at Ϫ80°C for antimicrobial susceptibility testing.
Antimicrobial susceptibility testing was conducted by the Agri-Food Laboratories Branch (AFLB), Food Safety Division of Alberta Agriculture, Food and Rural Development, Edmonton, AB and PDS, Saskatoon, SK, using a broth microdilution technique and following Clinical and Laboratory Standards Institute (CLSI) guidelines. 13, 14 National Antimicrobial Resistance Monitoring System (NARMS) minimum inhibitory concentration (MIC) CMV7CNCD susceptibility panels (Sensititre™, TREK Diagnostic Systems, Westlake, Ohio) were used to test isolates for susceptibility to 16 antimicrobials across a standard range of dilutions (Table 2) . Each isolate was grown up on a nonselective medium. A 0.5 McFarland standard was made in 5 ml of demineralized water of which 10 l was transferred into 11 ml of cation-adjusted Mueller-Hinton broth with TES buffer. A 50-l aliquot was inoculated into each of the 96 wells on the panel. Inoculated plates were incubated and read by the Sensititre ARIS ® (Automated Reading and Incubation System) (TREK Diagnostic Systems, Inc., Westlake, OH). Readings were transferred to Sensititre Automated Microbiology Systems (SAMS) computer software (TREK Diagnostic Systems) and interpreted according to CLSI breakpoints for animals or humans. 13, 14 The MIC breakpoint for streptomycin, which does not have a CLSI guideline, was taken from the NARMS 2000 E. coli report. 49 
Antimicrobial use data collection-exposure through feed and water
Each herd owner or manager used existing records to complete surveys on antimicrobial use through feed and water. Data for each exposure of suckling, nursery, grow-finish pig, or sows in the previous 12 months included the product used, number of pigs exposed, and duration of exposure. Antimicrobial use was described as the exposure per pig-day and scaled by 1,000 or 100,000 to facilitate interpretation (Equation 1). Each day, antimicrobials were offered was an exposure event. Every herd had an open population, with animals entering and leaving the herd during previous 12 months. The population-at-risk was the average number of pigs moved into and out of each phase over this time. 17 This assumed mortality and culls occurred, on average, halfway through each phase. The time-at-risk was the average number of days spent in each phase. Time-weighted averages accounted for groups of pigs within a phase with different durations at risk. This occurred in herds where animals were sold as breeding stock or batches of nursery pigs were sold at a younger age than the typical transfer age to grow-finish. Pigs could be exposed more than once per day, either through products in both feed and water, or through products containing multiple antimicrobials. where E ϭ exposed and R ϭ at risk. a Risk factors models developed for resistance phenotypes observed in more than 5% of the isolates.
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Statistical analysis
Antimicrobial exposure and susceptibility data were maintained in a relational database (Microsoft Access, Microsoft Corporation, Redmond, WA). Descriptive statistics were calculated using commercially available software (Microsoft Excel, Microsoft Corporation, Redmond, WA). Intermediate MIC values were classified as susceptible for all analyses. Statistical models, adjusted for herd-level clustering using generalized estimating equations (GEE) (PROC GENMOD, SAS version 9.1, SAS Institute Inc., Cary, NC), had a logit-link function, binomial distribution, and an exchangeable correlation structure. When necessary, extrabinomial variation was allowed by a scale parameter equal to the square root of the Pearson's chi-square divided by the degrees of freedom in the model.
The prevalence of resistance to each antimicrobial was calculated using the intercept (␤ 0 ) and 95% confidence intervals (CI) from a null binomial response model in 1/[1 ϩ exp(Ϫ␤ 0 )]. 17 A risk factor model was developed for each resistance that was observed in more than 5% of the isolates. Models were restricted to these drug resistances to minimize problems with power, model stability, and convergence associated with infrequent outcomes.
In contrast to AMR, which was described for individual drugs, antimicrobial exposures were described by class. An antimicrobial class refers to drugs with similar chemical structures and mechanisms of action. 39, 53 The antimicrobials used by study herds were classified as follows: (1) aminocyclitols, (2) aminoglycosides, (3) ␤-lactams, (4) macrolides (included lincosamides and pleuromutilins), (5) sulfonamides, and (6) tetracyclines. Antimicrobial use was further stratified by the production phase exposed: suckling, nursery, grow-finish pigs, and sows. Antimicrobial use variables used in five or more herds were modeled as the exposure rate (continuous). Variables used in less than five herds were collapsed to "any use" versus "no use" (dichotomous), whereas those used by only one herd were not evaluated.
The outcome of each model was the proportion of isolates from a sample that were resistant to the antimicrobial. Each antimicrobial use variable was screened to determine its unconditional association with the outcome variable; only those significant at p Ͻ 0.2 were considered further. For continuous antimicrobial use variables, the effect estimate of each quartile was graphed against the log odds of the outcome to assess the relationship for linearity. Nonlinear associations were addressed by categorizing antimicrobial use as no use, low use (0.1-500 exposures/1,000 pig-days), and high use (Ͼ500 exposures/1,000 pig-days) because this categorization best fit the variable distribution. Categorical variables were considered further if significant at p Ͻ 0.2.
All antimicrobial use variables with an unconditional p Ͻ 0.2 were included in the full model. Manual step-wise backward selection was used to develop a main effects model, retaining only antimicrobial use variables significant at p Ͻ 0.05. Variables describing exposure to the same antimicrobial class as the outcome were retained, regardless of significance, until all other nonsignificant variables were eliminated. For example, when modeling resistance to sulfamethoxazole, variables describing sulfonamide use were retained until all nonsignificant variables describing other classes were removed. This modeling decision was based on the premise that direct selection and cross-resistance affect resistance rates more strongly than co-selection.
Variables removed from the full model were reintroduced into the main effects model separately to ensure they had not been inappropriately removed because of confounding. Twoway interactions were considered between exposures in the same swine production phase. Interaction terms, significant at p Ͻ 0.05, were retained in the final model along with their main effects. Production variables were considered as potential confounders ( Table 1 ). Those that altered a parameter estimate by more than 25% were retained in the final model. Residuals of the final models were examined visually for outliers. The association between each variable of interest and the outcome was reported as an odds ratio (OR ϭ exp␤) with 95% CI. 17 
RESULTS
A total of 405 samples were cultured for E. coli. On average, 63 isolates were harvested per herd (range, 60-88) for a total of 1,439 isolates. More than 5% of the E. coli were resistant to 7 of the 16 antimicrobials in the panel (Table 2 ). Resistance to ampicillin, streptomycin, sulfamethoxazole, and tetracycline were each observed in isolates from every herd. One herd had no isolates resistant to chloramphenicol, four had no isolates resistant to trimethoprim-sulfamethoxazole, and five had no isolates resistant to kanamycin. These isolates demonstrated 92 unique resistance patterns, 70 of which occurred in less than 10 isolates. In all, 63 of the 405 pens sampled had every tested isolate demonstrate the same resistance pattern. However, in 62 of the 63 pens the tested isolates demonstrated unique MIC distributions. The MIC distributions were only identical in all isolates from 1 of the 405 pens examined.
In every herd, antimicrobials had been used in feed or water in the previous 12 months. Nursery pigs were exposed to antimicrobials most frequently while sows were exposed least frequently (Table 3) . Macrolides were used in 18 of 20 herds, tetracyclines in 15, ␤-lactams in 9, sulfonamides in 7, aminocyclitols in 6, and aminoglycosides in 6 (Table 4) .
Seven E. coli resistance outcomes were modeled against antimicrobial exposures through feed and water ( 
AER of all herds a
AER in herds with exposure rate Ͼ 0 these seven drugs, tetracycline was the only one that was used in feed or water in study herds. Tetracycline exposures included tetracycline, oxytetracycline, and chlortetracycline. Resistance to sulfamethoxazole was also modeled; because the sulfonamide derivative was not always reported, we cannot definitively state this drug was not used in study herds. However, sulfamethoxazole is not licensed for use in Canadian pigs whereas the following sulfonamides are licensed for administration through feed or water: sulfadoxine, sulfaguanidine, sulfamerazine, sulfamethazine, sulfanilamide, sulfapyridine, and sulfathiazole. 35 Resistance to two aminoglycosides, kanamycin and streptomycin, were modeled. Neither of these drugs was used in study herds, but the aminoglycoside neomycin and the aminocyclitol spectinomycin were used. Two of the antimicrobials to which resistance was modeled were administered parenterally but not in feed or water. Trimethoprim, in combination with sulfadoxine, was used as an injectable product and thus was not captured by any of the antimicrobial exposure variables. Similarly, ampicillin was also only used as an injectable drug. ␤-Lactam use was predominantly penicillin G, although nursery pigs received amoxicillin through water in one herd.
Resistance to chloramphenicol was the only outcome where no product from its antimicrobial class was used in study herds. In contrast, macrolides were used extensively, but had no resistance outcomes tested. Macrolide exposures included tylosin, tilmicosin, tiamulin, and lincomycin.
Six of the seven antimicrobial resistance outcomes had significant antimicrobial use risk factors (Table 5 ). Three resistance outcomes were associated with exposure to drugs in the same antimicrobial class. Resistance to tetracycline was associated with exposure to tetracyclines in nursery pigs, resistance to ampicillin was associated with ␤-lactam use in grow-finish pigs and resistance to sulfamethoxazole was associated with sulfonamide use in nursery pigs. In contrast, E. coli resistance to kanamycin and streptomycin was not associated with aminoglycoside or aminocyclitol exposure. Resistance to streptomycin was predicted by macrolide exposure in grow-finish pigs (Table 5 ). Resistance to kanamycin was the only outcome with no significant antimicrobial use risk factors.
Resistance to sulfamethoxazole was associated with two types of nursery pig exposures: sulfonamides and aminoglycosides. Resistance to sulfamethoxazole was also predicted by two macrolide use variables. Macrolide use in suckling pigs increased the odds of sulfamethoxazole resistance. Similarly, E. coli from herds with a high rate of macrolide use in grow-finish pigs had 2.6 times higher odds (95% CI, 1.5-4.3; p ϭ 0.0004) of resistance than isolates from herds using a low rate, and 6.0 times (p Ͻ 0.0001) higher odds of resistance than E. coli from herds using none. The odds of resistance to sulfamethoxazole were 2.3 times higher (95% CI, 1.4-3.9; p ϭ 0.0009) in isolates from herds using a low rate of macrolides in grow-finish pigs compared to herds with no use. 
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Herds reporting AER Ͼ 0 a
The odds of trimethoprim-sulfamethoxazole resistance increased with four antimicrobial use variables, including sulfonamide use in nursery pigs (Table 5 ). In contrast, nursery pig exposure to tetracycline was associated with decreased odds of resistance. Resistance to trimethoprim-sulfamethoxazole was the only outcome associated with antimicrobial use in sows. It was also the only model with an important confounder; E. coli from herds selling breeding stock were more likely to be resistant to trimethoprim-sulfamethoxazole than isolates from herds that only sold pigs for consumption.
The odds of E. coli resistance to chloramphenicol increased with aminoglycoside exposure and decreased with tetracycline exposure in suckling pigs (Table 5 ). Macrolide use in grow-finish pigs was also significant; the odds of chloramphenicol resistance were 4.1 times higher (95% CI, 2.2-7.6; p Ͻ 0.0001) in isolates from herds with high exposure compared to low exposure, and 5.9 times higher (p ϭ 0.0006) in isolates from herds with high exposure compared to no exposure. The odds of resistance to chloramphenicol were not significantly different between E. coli from herds with low macrolide exposure compared to those with no exposure (p ϭ 0.4).
DISCUSSION
Antimicrobial resistance is a natural consequence of drug selective pressures. In swine herds, these pressures may be intensified because of long-term antimicrobial exposure through water and feed. 40 Therefore, this study investigated the link between herd level antimicrobial use through feed and water and resistance of E. coli. Although this study considered E. coli grow-finish pigs only, AMR was associated with antimicrobial use in all production phases. This indicates that antimicrobial use in pigs distant from market may have food safety repercussions. Five of the resistance outcomes were associated with exposure to unrelated drugs, suggesting co-selection. 36, 46 Although co-selection is familiar to scientists, producers and veterinarians need to understand this phenomenon before AMR can be addressed at the herd level.
In general, the statistical models generated by this study indicate that antimicrobial exposure provides a competitive advantage to resistant E. coli. Three aspects of acquired AMR guided our interpretation of these models. Direct selection occurs when exposure to a drug results in increased resistance to ROSENGREN ET AL. 266 the same drug. Cross resistance occurs when resistance to a drug automatically confers resistance to a related drug. Finally, exposure to any drug in a multiple drug-resistant phenotype creates selective pressure for every resistance in the phenotype (coselection). 36, 46 The association between tetracycline resistance and exposure was interpreted as both direct selection and cross resistance, while the association between sulfamethoxazole resistance and sulfonamide use implied cross selection, and the association between chloramphenicol resistance and aminoglycoside exposure suggested co-selection. Enterobacteriaceae are intrinsically resistant to penicillin G. 37 Because penicillin G was the only ␤-lactam used in growfinish pigs, the association between ampicillin resistance and ␤-lactam exposure does not fit our understanding of cross selection. It is difficult to accept that low rates of exposure to a drug that is inactive against E. coli could cause this increase in ampicillin resistance. Rather, it seems more plausible that ␤-lactam exposure was a proxy for a common, undefined risk factor. However, the possibility that penicillin G is a true risk factor for ampicillin resistance cannot be discounted; others have reported an association between ampicillin resistance in E. coli from grow-finish pigs and penicillin G use in lactating sows. 19 Investigating this association in more herds, with a wider range of ␤-lactam exposures, might clarify this finding.
Neomycin and spectinomycin were used in study herds, yet these exposures were not associated with resistance to kanamycin or streptomycin. This was unexpected because resistance genes encoding for both streptomycin and spectinomycin (strA/strB, aadA) have been reported in E. coli from Canadian pigs. 9, 31 Thus, assuming spectinomycin use directly selects for resistance, it would also select for resistance to streptomycin. Such a relationship between spectinomycin use and streptomycin resistance has been previously reported. 2 A similar relationship exists between kanamycin and neomycin; resistance to both drugs is encoded for by aac(3)IV and aph(3Ј)-Ia, and these genes have been identified in E. coli from Canadian pigs. 9, 31 This study's design might explain the failure to identify associations between aminoglycoside resistance and these exposures. These antimicrobial classes were only used in suckling and nursery pigs, whereas E. coli was from grow-finish pigs. Other researchers have observed that E. coli resistance to apramycin declines rapidly following the removal of apramycin from feed. Thus, if aminoglycoside use had an effect on resistance, it may have dissipated before isolate collection in this study. 29, 30 Finding chloramphenicol resistance in these E. coli demonstrates that antimicrobial resistance can exist and persist without direct selection. Canadian authorities banned chloramphenicol use in food animals in 1985 and no study herds used the related approved drug florfenicol. 23 Antimicrobial exposure can increase resistance to unrelated drugs by selecting for multiple resistant organisms. 44, 46 Others have reported physical linkages and statistical associations between chloramphenicol and aminoglycoside resistance genes. This supports our conclusion that chloramphenicol resistance might be persisting because of aminoglycoside use in suckling piglets and macrolide use in grow-finish pigs. 8, 31, 48 A report of increased odds of chloramphenicol resistance in herds adding tylosin to finisher diets further supports this statement. 2 Identifying macrolide use as a risk factor for four different resistance outcomes was striking because E. coli is intrinsically resistant to macrolides (MICs of Յ250 g/ml). 4, 38 However, another description of on-farm antimicrobial use and resistance also found macrolide use was a risk factor for various E. coli resistances in pigs. 2 In humans, when erythromycin is administered orally, the intestinal concentration exceeds the intrinsic resistance of E. coli. 3, 4 This suppresses the aerobic Gram-negative intestinal flora and selects for erythromycin-resistant E. coli (MIC Ն 500 g/ml). 3, 4 E. coli, isolated from people receiving erythromycin, can carry transmissible plasmids with linked erythromycin, ampicillin, gentamicin, and streptomycin resistance genes. 3, 4 In pigs, E. coli resistances to tylosin, tilmicosin, lincomycin, and tiamulin have not been investigated. The intestinal and colonic concentrations of these antimicrobials have only been estimated. 10 Considering the situation in humans, it is plausible that macrolide-resistant E. coli exists in pigs. Investigations into the E. coli MIC distributions to these drugs, the macrolide-resistance genes in E. coli and their links to other AMR genes are needed. Providing a biological explanation for the macrolide risk factors identified in these models could motivate the swine industry to use macrolide antimicrobials differently. Currently, tylosin is among the most commonly used antimicrobial in grow-finish pigs. 11, 18, 40 Similar to other observational studies, antimicrobial use in other production phases was associated with E. coli AMR in grow-finish pigs in this study. 2, 19, 26 These findings have been supported experimentally; offspring from sows receiving oxytetracycline in feed prefarrowing had increased oxytetracycline resistance compared to control piglets. 30 Thus, AMR risk factor studies should encompass the entire herd. Equally important, antimicrobials should always be used sparingly in all ages of pigs.
Two of our statistical models identified decreased odds of AMR with increased antimicrobial exposure. Similar to this study, Akwar reported a negative association between chloramphenicol resistance and tetracycline exposure. 2 This could be explained by incompatible resistance genes, because catA1 and tetB have been found to be negatively associated. 48 The finding of decreasing resistance with increased antimicrobial use is counterintuitive; when statistical models identify counterintuitive associations, researchers often discount them as spurious. In our case, corroborating findings between studies strengthens the premise that the statistical associations reflect biological reality and underlines the importance of heeding unexpected or conflicting results.
The frequency of AMR in these E. coli was similar to surveillance reports from abattoirs and swine herds in North America. 2, 19, 25, 50 Although descriptions of antimicrobial use in North American pigs are scarce, the number of herds using group medications and the types of drugs used in the current study were comparable to available data. 11, 20, 40 The similarity of the antimicrobial use and resistance between this and other reports, and the lack of confounding by management variables, indicates these findings are relevant to many swine farms in North America.
Reporting dose-response relationships between AMR and antimicrobial use through feed and water is unique. Previous risk factor studies have described antimicrobial use in feed and water qualitatively, while we described the rate of exposure. 2, 19 Assuming a causal relationship, long-term or indiscriminant antimicrobial use in pigs affects AMR more than targeted use. Describing antimicrobial use as an exposure rate provides op-portunities to identify threshold exposures that qualitative descriptions would miss. Despite these strengths, our description of antimicrobial use was also a primary weakness of this study. Six of the 15 antimicrobial exposure variables were not used in enough herds to consider dose-response relationships. As well, there were not enough study herds to describe antimicrobial exposures to individual drugs. Each drug was used in only a few herds, and co-linearity problems between drugs, particularly those administered as combination products, were encountered. Describing antimicrobial exposure by class partially addressed these problems. However, it may have biased associations toward the null. Pharmacokinetic characteristics, such as the rate of absorption, and physical characteristics, such as stability in gastric acid, can differ between drugs within a class. 39 If the selective pressure for resistance differed markedly between drugs within a class, this study may have missed significant associations, because exposure was defined by antimicrobial class. Future studies will need to enroll more herds or purposively select herds on the basis of antimicrobial use to evaluate individual drugs as risk factors.
Administering antimicrobials to pigs is a risk factor for antimicrobial resistance. Evidence of co-selection emphasizes that using older antimicrobials, which are considered of lesser importance to human medicine, is not risk free. 24, 53 Swine farms do not exist in isolation; people may consume resistant bacteria through contaminated pork. In light of food safety concerns surrounding antimicrobial resistance, these findings demonstrate the importance of judicious antimicrobial use in all aspects of swine production, not only in pigs close to slaughter.
